| Year |
Citation |
Score |
| 2020 |
Gallagher J, Rick J, Xie SX, Martinez-Martin P, Mamikonyan E, Chen-Plotkin A, Dahodwala N, Morley J, Duda JE, Trojanowski JQ, Siderowf A, Weintraub D. Psychometric Properties of the Clinical Dementia Rating Scale Sum of Boxes in Parkinson's Disease. Journal of Parkinson's Disease. PMID 33386814 DOI: 10.3233/JPD-202390 |
0.304 |
|
| 2020 |
Robinson JL, Porta S, Garrett FG, Zhang P, Xie SX, Suh E, Van Deerlin VM, Abner EL, Jicha GA, Barber JM, Lee VM, Lee EB, Trojanowski JQ, Nelson PT. Limbic-predominant age-related TDP-43 encephalopathy differs from frontotemporal lobar degeneration. Brain : a Journal of Neurology. PMID 32830216 DOI: 10.1093/Brain/Awaa219 |
0.327 |
|
| 2020 |
Purri R, Brennan L, Rick J, Xie SX, Deck BL, Chahine LM, Dahodwala N, Chen-Plotkin A, Duda JE, Morley JF, Akhtar RS, Trojanowski JQ, Siderowf A, Weintraub D. Subjective Cognitive Complaint in Parkinson's Disease Patients with Normal Cognition: Canary in the Coal Mine? Movement Disorders : Official Journal of the Movement Disorder Society. PMID 32520435 DOI: 10.1002/Mds.28115 |
0.381 |
|
| 2020 |
Kovacs GG, Lukic MJ, Irwin DJ, Arzberger T, Respondek G, Lee EB, Coughlin D, Giese A, Grossman M, Kurz C, McMillan CT, Gelpi E, Compta Y, van Swieten JC, Laat LD, ... ... Xie SX, et al. Distribution patterns of tau pathology in progressive supranuclear palsy. Acta Neuropathologica. PMID 32383020 DOI: 10.1007/S00401-020-02158-2 |
0.324 |
|
| 2019 |
Robinson JL, Yan N, Caswell C, Xie SX, Suh E, Van Deerlin VM, Gibbons G, Irwin DJ, Grossman M, Lee EB, Lee VM, Miller B, Trojanowski JQ. Primary Tau Pathology, Not Copathology, Correlates With Clinical Symptoms in PSP and CBD. Journal of Neuropathology and Experimental Neurology. PMID 31999351 DOI: 10.1093/Jnen/Nlz141 |
0.386 |
|
| 2019 |
Horn S, Richardson H, Xie SX, Weintraub D, Dahodwala N. Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson's disease and dementia with Lewy bodies. Parkinsonism & Related Disorders. 69: 119-124. PMID 31751863 DOI: 10.1016/J.Parkreldis.2019.11.009 |
0.385 |
|
| 2019 |
Deck BL, Xie SX, Choi G, Rick J, Siderowf A, Rudovsky S, Chen-Plotkin A, Duda JE, Morley JF, Dahodwala N, Trojanowski JQ, Weintraub D. Cognitive Functional Abilities in Parkinson's Disease: Agreement Between Patients and Informants. Movement Disorders Clinical Practice. 6: 440-445. PMID 31392244 DOI: 10.1002/Mdc3.12781 |
0.386 |
|
| 2019 |
Phillips JS, Da Re F, Irwin DJ, McMillan CT, Vaishnavi SN, Xie SX, Lee EB, Cook PA, Gee JC, Shaw LM, Trojanowski JQ, Wolk DA, Grossman M. Longitudinal progression of grey matter atrophy in non-amnestic Alzheimer's disease. Brain : a Journal of Neurology. 142: 1701-1722. PMID 31135048 DOI: 10.1093/Brain/Awz091 |
0.415 |
|
| 2019 |
Rennert L, Xie SX. Bias induced by ignoring double truncation inherent in autopsy-confirmed survival studies of neurodegenerative diseases. Statistics in Medicine. PMID 31062392 DOI: 10.1002/Sim.8185 |
0.347 |
|
| 2019 |
Alber J, Alladi S, Bae HJ, Barton DA, Beckett LA, Bell JM, Berman SE, Biessels GJ, Black SE, Bos I, Bowman GL, Brai E, Brickman AM, Callahan BL, Corriveau RA, ... ... Xie SX, et al. White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities. Alzheimer's & Dementia (New York, N. Y.). 5: 107-117. PMID 31011621 DOI: 10.1016/J.Trci.2019.02.001 |
0.414 |
|
| 2019 |
Tropea TF, Mak J, Guo MH, Xie SX, Suh E, Rick J, Siderowf A, Weintraub D, Grossman M, Irwin D, Wolk DA, Trojanowski JQ, Van Deerlin V, Chen-Plotkin AS. TMEM106B Effect on Cognition in Parkinson's Disease and Frontotemporal Dementia. Annals of Neurology. PMID 30973966 DOI: 10.1002/Ana.25486 |
0.416 |
|
| 2019 |
Giannini LA, Xie SX, McMillan CT, Liang M, Williams A, Jester C, Rascovsky K, Wolk DA, Ash S, Lee EB, Trojanowski JQ, Grossman M, Irwin DJ. Divergent Patterns of TDP-43 and Tau Pathologies in Primary Progressive Aphasia. Annals of Neurology. PMID 30851133 DOI: 10.1002/Ana.25465 |
0.328 |
|
| 2019 |
Massimo L, Rennert L, Xie S, Irwin D, Grossman M, McMillan C. Genetic Variations Hasten Decline in Young Onset Dementia Nursing Outlook. 67: 116-117. DOI: 10.1016/J.Outlook.2018.12.029 |
0.33 |
|
| 2018 |
Coughlin DG, Xie SX, Liang M, Williams A, Peterson C, Weintraub D, McMillan CT, Wolk DA, Akhtar RS, Hurtig H, Coslett HB, Hamilton R, Siderowf A, Duda JE, Rascovsky K, et al. Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders. Annals of Neurology. PMID 30549331 DOI: 10.1002/Ana.25392 |
0.418 |
|
| 2018 |
Smith KM, Ash S, Xie SX, Grossman M. Evaluation of Linguistic Markers of Word-Finding Difficulty and Cognition in Parkinson's Disease. Journal of Speech, Language, and Hearing Research : Jslhr. 1-9. PMID 29955824 DOI: 10.1044/2018_Jslhr-L-17-0304 |
0.368 |
|
| 2018 |
Robinson JL, Corrada MM, Kovacs GG, Dominique M, Caswell C, Xie SX, Lee VM, Kawas CH, Trojanowski JQ. Non-Alzheimer's contributions to dementia and cognitive resilience in The 90+ Study. Acta Neuropathologica. PMID 29916037 DOI: 10.1007/S00401-018-1872-5 |
0.408 |
|
| 2018 |
Kovacs GG, Xie SX, Robinson JL, Lee EB, Smith DH, Schuck T, Lee VM, Trojanowski JQ. Sequential stages and distribution patterns of aging-related tau astrogliopathy (ARTAG) in the human brain. Acta Neuropathologica Communications. 6: 50. PMID 29891013 DOI: 10.1186/S40478-018-0552-Y |
0.315 |
|
| 2018 |
Robinson JL, Lee EB, Xie SX, Rennert L, Suh E, Bredenberg C, Caswell C, Van Deerlin VM, Yan N, Yousef A, Hurtig HI, Siderowf A, Grossman M, McMillan CT, Miller B, et al. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Brain : a Journal of Neurology. PMID 29878075 DOI: 10.1093/Brain/Awy146 |
0.389 |
|
| 2018 |
Massimo L, Xie SX, Rennert L, Fick DM, Halpin A, Placek K, Williams A, Rascovsky K, Irwin DJ, Grossman M, McMillan CT. Occupational attainment influences longitudinal decline in behavioral variant frontotemporal degeneration. Brain Imaging and Behavior. PMID 29542053 DOI: 10.1007/S11682-018-9852-X |
0.368 |
|
| 2018 |
Wisse LEM, Das SR, Davatzikos C, Dickerson BC, Xie SX, Yushkevich PA, Wolk DA. Defining SNAP by cross-sectional and longitudinal definitions of neurodegeneration. Neuroimage. Clinical. 18: 407-412. PMID 29487798 DOI: 10.1016/J.Nicl.2018.02.008 |
0.306 |
|
| 2018 |
Mao JJ, Xie S, Duhamel K, Bao T, Kantoff PW, Li QS, Barg F, Song S, Gehrman P, Garland SN. The effect of acupuncture versus cognitive behavior therapy on insomnia in cancer survivors: A randomized clinical trial. Journal of Clinical Oncology. 36: 10001-10001. DOI: 10.1200/Jco.2018.36.15_Suppl.10001 |
0.318 |
|
| 2017 |
Irwin DJ, McMillan CT, Xie SX, Rascovsky K, Van Deerlin VM, Coslett HB, Hamilton R, Aguirre G, Lee EB, Lee VMY, Trojanowski JQ, Grossman M. Asymmetry of post-mortem neuropathology in behavioural-variant frontotemporal dementia. Brain : a Journal of Neurology. PMID 29228211 DOI: 10.1093/Brain/Awx319 |
0.352 |
|
| 2017 |
Phillips JS, Da Re F, Dratch L, Xie SX, Irwin DJ, McMillan CT, Vaishnavi SN, Ferrarese C, Lee EB, Shaw LM, Trojanowski JQ, Wolk DA, Grossman M. Neocortical origin and progression of gray matter atrophy in nonamnestic Alzheimer's disease. Neurobiology of Aging. 63: 75-87. PMID 29223682 DOI: 10.1016/J.Neurobiolaging.2017.11.008 |
0.368 |
|
| 2017 |
Tropea TF, Xie SX, Rick J, Chahine LM, Dahodwala N, Doshi J, Davatzikos C, Shaw LM, Van Deerlin V, Trojanowski JQ, Weintraub D, Chen-Plotkin AS. APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29168904 DOI: 10.1002/Mds.27204 |
0.425 |
|
| 2017 |
Deck BL, Rick J, Xie SX, Chen-Plotkin A, Duda JE, Morley JF, Chahine LM, Dahodwala N, Trojanowski JQ, Weintraub D. Statins and Cognition in Parkinson's Disease. Journal of Parkinson's Disease. PMID 28922167 DOI: 10.3233/Jpd-171113 |
0.366 |
|
| 2017 |
Irwin DJ, Lleó A, Xie SX, McMillan CT, Wolk D, Lee EB, Van Deerlin VM, Shaw LM, Trojanowski JQ, Grossman M. Ante mortem CSF tau levels correlate with post mortem tau pathology in FTLD. Annals of Neurology. PMID 28719018 DOI: 10.1002/Ana.24996 |
0.35 |
|
| 2017 |
Akhtar RS, Xie SX, Chen YJ, Rick J, Gross RG, Nasrallah IM, Van Deerlin VM, Trojanowski JQ, Chen-Plotkin AS, Hurtig HI, Siderowf AD, Dubroff JG, Weintraub D. Regional brain amyloid-β accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia. Plos One. 12: e0177924. PMID 28542444 DOI: 10.1371/Journal.Pone.0177924 |
0.384 |
|
| 2017 |
Koenig AM, Mechanic-Hamilton D, Xie SX, Combs MF, Cappola AR, Xie L, Detre JA, Wolk DA, Arnold SE. Effects of the Insulin Sensitizer Metformin in Alzheimer Disease: Pilot Data From a Randomized Placebo-controlled Crossover Study. Alzheimer Disease and Associated Disorders. 31: 107-113. PMID 28538088 DOI: 10.1097/Wad.0000000000000202 |
0.384 |
|
| 2017 |
Brennan L, Devlin KM, Xie SX, Mechanic-Hamilton D, Tran B, Hurtig HH, Chen-Plotkin A, Chahine LM, Morley JF, Duda JE, Roalf DR, Dahodwala N, Rick J, Trojanowski JQ, Moberg PJ, et al. Neuropsychological Subgroups in Non-Demented Parkinson's Disease: A Latent Class Analysis. Journal of Parkinson's Disease. PMID 28387684 DOI: 10.3233/Jpd-171081 |
0.373 |
|
| 2017 |
Kovacs GG, Robinson JL, Xie SX, Lee EB, Grossman M, Wolk DA, Irwin DJ, Weintraub D, Kim CF, Schuck T, Yousef A, Wagner ST, Suh E, Van Deerlin VM, Lee VM, et al. Evaluating the Patterns of Aging-Related Tau Astrogliopathy Unravels Novel Insights Into Brain Aging and Neurodegenerative Diseases. Journal of Neuropathology and Experimental Neurology. PMID 28340083 DOI: 10.1093/Jnen/Nlx007 |
0.359 |
|
| 2017 |
Cooper CA, Jain N, Gallagher MD, Weintraub D, Xie SX, Berlyand Y, Espay AJ, Quinn J, Edwards KL, Montine T, Van Deerlin VM, Trojanowski J, Zabetian CP, Chen-Plotkin AS. Common variant rs356182 near SNCA defines a Parkinson's disease endophenotype. Annals of Clinical and Translational Neurology. 4: 15-25. PMID 28078311 DOI: 10.1002/Acn3.371 |
0.325 |
|
| 2017 |
Irwin DJ, Grossman M, Weintraub D, Hurtig HI, Duda JE, Xie SX, Lee EB, Van Deerlin VM, Lopez OL, Kofler JK, Nelson PT, Jicha GA, Woltjer R, Quinn JF, Kaye J, et al. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. The Lancet. Neurology. 16: 55-65. PMID 27979356 DOI: 10.1016/S1474-4422(16)30291-5 |
0.32 |
|
| 2016 |
Akhtar RS, Xie SX, Brennan L, Pontecorvo MJ, Hurtig HI, Trojanowski JQ, Weintraub D, Siderowf AD. Amyloid-Beta Positron Emission Tomography Imaging of Alzheimer's Pathology in Parkinson's Disease Dementia. Movement Disorders Clinical Practice. 3: 367-375. PMID 27500181 DOI: 10.1002/Mdc3.12290 |
0.39 |
|
| 2016 |
Lim NS, Swanson CR, Cherng HR, Unger TL, Xie SX, Weintraub D, Marek K, Stern MB, Siderowf A, Trojanowski JQ, Chen-Plotkin AS. Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease. Annals of Clinical and Translational Neurology. 3: 346-55. PMID 27231704 DOI: 10.1002/Acn3.299 |
0.422 |
|
| 2016 |
Chahine LM, Xie SX, Simuni T, Tran B, Postuma R, Amara A, Oertel WH, Iranzo A, Scordia C, Fullard M, Linder C, Purri R, Darin A, Rennert L, Videnovic A, et al. Longitudinal changes in cognition in early Parkinson's disease patients with REM sleep behavior disorder. Parkinsonism & Related Disorders. PMID 27010070 DOI: 10.1016/J.Parkreldis.2016.03.006 |
0.365 |
|
| 2016 |
Garland SN, Gehrman P, Barg FK, Xie SX, Mao JJ. CHoosing Options for Insomnia in Cancer Effectively (CHOICE): Design of a patient centered comparative effectiveness trial of acupuncture and cognitive behavior therapy for insomnia. Contemporary Clinical Trials. PMID 26956541 DOI: 10.1016/J.Cct.2016.02.010 |
0.305 |
|
| 2016 |
Brennan L, Siderowf A, Rubright JD, Rick J, Dahodwala N, Duda JE, Hurtig H, Stern M, Xie SX, Rennert L, Karlawish J, Shea JA, Trojanowski JQ, Weintraub D. The Penn Parkinson's Daily Activities Questionnaire-15: Psychometric properties of a brief assessment of cognitive instrumental activities of daily living in Parkinson's disease. Parkinsonism & Related Disorders. PMID 26923524 DOI: 10.1016/J.Parkreldis.2016.02.020 |
0.37 |
|
| 2016 |
Fullard ME, Tran B, Xie SX, Toledo JB, Scordia C, Linder C, Purri R, Weintraub D, Duda JE, Chahine LM, Morley JF. Olfactory impairment predicts cognitive decline in early Parkinson's disease. Parkinsonism & Related Disorders. PMID 26923521 DOI: 10.1016/J.Parkreldis.2016.02.013 |
0.379 |
|
| 2016 |
White MT, Shaw LM, Xie SX. Evaluation of Cerebrospinal Fluid Assay Variability in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. 51: 463-70. PMID 26890778 DOI: 10.3233/Jad-151045 |
0.353 |
|
| 2016 |
Moelter ST, Weintraub D, Mace L, Cary M, Sullo E, Xie SX, Karlawish J. Research consent capacity varies with executive function and memory in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 31: 414-7. PMID 26861463 DOI: 10.1002/Mds.26469 |
0.319 |
|
| 2016 |
Berlyand Y, Weintraub D, Xie SX, Mellis IA, Doshi J, Rick J, McBride J, Davatzikos C, Shaw LM, Hurtig H, Trojanowski JQ, Chen-Plotkin AS. An Alzheimer's Disease-Derived Biomarker Signature Identifies Parkinson's Disease Patients with Dementia. Plos One. 11: e0147319. PMID 26812251 DOI: 10.1371/Journal.Pone.0147319 |
0.439 |
|
| 2015 |
Leung YY, Toledo JB, Nefedov A, Polikar R, Raghavan N, Xie SX, Farnum M, Schultz T, Baek Y, Deerlin VV, Hu WT, Holtzman DM, Fagan AM, Perrin RJ, Grossman M, et al. Identifying amyloid pathology-related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study. Alzheimer's & Dementia (Amsterdam, Netherlands). 1: 339-348. PMID 26693175 DOI: 10.1016/J.Dadm.2015.06.008 |
0.406 |
|
| 2015 |
Irwin DJ, Byrne MD, McMillan CT, Cooper F, Arnold SE, Lee EB, Van Deerlin VM, Xie SX, Lee VM, Grossman M, Trojanowski JQ. Semi-Automated Digital Image Analysis of Pick's Disease and TDP-3 Proteinopathy. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. PMID 26538548 DOI: 10.1369/0022155415614303 |
0.319 |
|
| 2015 |
Smith KM, Xie SX, Weintraub D. Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 26534930 DOI: 10.1136/Jnnp-2015-311827 |
0.327 |
|
| 2015 |
Bilello M, Doshi J, Nabavizadeh SA, Toledo JB, Erus G, Xie SX, Trojanowski JQ, Han X, Davatzikos C. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 26402108 DOI: 10.3233/Jad-150400 |
0.411 |
|
| 2015 |
Pigott K, Rick J, Xie SX, Hurtig H, Chen-Plotkin A, Duda JE, Morley JF, Chahine LM, Dahodwala N, Akhtar RS, Siderowf A, Trojanowski JQ, Weintraub D. Longitudinal study of normal cognition in Parkinson disease. Neurology. PMID 26362285 DOI: 10.1212/Wnl.0000000000002001 |
0.372 |
|
| 2015 |
Brennan L, Siderowf A, Rubright JD, Rick J, Dahodwala N, Duda JE, Hurtig H, Stern M, Xie SX, Rennert L, Karlawish J, Shea JA, Trojanowski JQ, Weintraub D. Development and initial testing of the Penn Parkinson's Daily Activities Questionnaire. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26249849 DOI: 10.1002/Mds.26339 |
0.324 |
|
| 2015 |
Swanson CR, Berlyand Y, Xie SX, Alcalay RN, Chahine LM, Chen-Plotkin AS. Plasma apolipoprotein A1 associates with age at onset and motor severity in early Parkinson's disease patients. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1648-56. PMID 26207725 DOI: 10.1002/Mds.26290 |
0.314 |
|
| 2015 |
Suh E, Lee EB, Neal D, Wood EM, Toledo JB, Rennert L, Irwin DJ, McMillan CT, Krock B, Elman LB, McCluskey LF, Grossman M, Xie SX, Trojanowski JQ, Van Deerlin VM. Semi-automated quantification of C9orf72 expansion size reveals inverse correlation between hexanucleotide repeat number and disease duration in frontotemporal degeneration. Acta Neuropathologica. PMID 26022924 DOI: 10.1007/S00401-015-1445-9 |
0.317 |
|
| 2015 |
Mamikonyan E, Xie SX, Melvin E, Weintraub D. Rivastigmine for mild cognitive impairment in Parkinson disease: A placebo-controlled study. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 912-8. PMID 25914281 DOI: 10.1002/Mds.26236 |
0.409 |
|
| 2015 |
Massimo L, Zee J, Xie SX, McMillan CT, Rascovsky K, Irwin DJ, Kolanowski A, Grossman M. Occupational attainment influences survival in autopsy-confirmed frontotemporal degeneration. Neurology. 84: 2070-5. PMID 25904687 DOI: 10.1212/Wnl.0000000000001595 |
0.335 |
|
| 2015 |
Russ J, Liu EY, Wu K, Neal D, Suh E, Irwin DJ, McMillan CT, Harms MB, Cairns NJ, Wood EM, Xie SX, Elman L, McCluskey L, Grossman M, Van Deerlin VM, et al. Hypermethylation of repeat expanded C9orf72 is a clinical and molecular disease modifier. Acta Neuropathologica. 129: 39-52. PMID 25388784 DOI: 10.1007/S00401-014-1365-0 |
0.305 |
|
| 2015 |
Moelter ST, Glenn MA, Xie SX, Chittams J, Clark CM, Watson M, Arnold SE. The Dementia Severity Rating Scale predicts clinical dementia rating sum of boxes scores. Alzheimer Disease and Associated Disorders. 29: 158-60. PMID 24770371 DOI: 10.1097/Wad.0000000000000031 |
0.311 |
|
| 2014 |
de la Riva P, Smith K, Xie SX, Weintraub D. Course of psychiatric symptoms and global cognition in early Parkinson disease. Neurology. 83: 1096-103. PMID 25128183 DOI: 10.1212/Wnl.0000000000000801 |
0.356 |
|
| 2014 |
Papay K, Xie SX, Stern M, Hurtig H, Siderowf A, Duda JE, Minger J, Weintraub D. Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study. Neurology. 83: 826-33. PMID 25037206 DOI: 10.1212/Wnl.0000000000000729 |
0.326 |
|
| 2014 |
Toledo JB, Da X, Weiner MW, Wolk DA, Xie SX, Arnold SE, Davatzikos C, Shaw LM, Trojanowski JQ. CSF Apo-E levels associate with cognitive decline and MRI changes. Acta Neuropathologica. 127: 621-32. PMID 24385135 DOI: 10.1007/S00401-013-1236-0 |
0.344 |
|
| 2014 |
Da X, Toledo JB, Zee J, Wolk DA, Xie SX, Ou Y, Shacklett A, Parmpi P, Shaw L, Trojanowski JQ, Davatzikos C. Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers. Neuroimage. Clinical. 4: 164-73. PMID 24371799 DOI: 10.1016/J.Nicl.2013.11.010 |
0.393 |
|
| 2014 |
Toledo JB, Van Deerlin VM, Lee EB, Suh E, Baek Y, Robinson JL, Xie SX, McBride J, Wood EM, Schuck T, Irwin DJ, Gross RG, Hurtig H, McCluskey L, Elman L, et al. A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 477-84.e1. PMID 23978324 DOI: 10.1016/J.Jalz.2013.06.003 |
0.315 |
|
| 2013 |
Stutzbach LD, Xie SX, Naj AC, Albin R, Gilman S, Lee VM, Trojanowski JQ, Devlin B, Schellenberg GD. The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer's disease. Acta Neuropathologica Communications. 1: 31. PMID 24252572 DOI: 10.1186/2051-5960-1-31 |
0.375 |
|
| 2013 |
Wang Z, Das SR, Xie SX, Arnold SE, Detre JA, Wolk DA. Arterial spin labeled MRI in prodromal Alzheimer's disease: A multi-site study. Neuroimage. Clinical. 2: 630-6. PMID 24179814 DOI: 10.1016/J.Nicl.2013.04.014 |
0.418 |
|
| 2013 |
Yarchoan M, Louneva N, Xie SX, Swenson FJ, Hu W, Soares H, Trojanowski JQ, Lee VM, Kling MA, Shaw LM, Chen-Plotkin A, Wolk DA, Arnold SE. Association of plasma C-reactive protein levels with the diagnosis of Alzheimer's disease. Journal of the Neurological Sciences. 333: 9-12. PMID 23978419 DOI: 10.1016/J.Jns.2013.05.028 |
0.378 |
|
| 2013 |
Karlawish J, Cary M, Moelter ST, Siderowf A, Sullo E, Xie S, Weintraub D. Cognitive impairment and PD patients' capacity to consent to research. Neurology. 81: 801-7. PMID 23892706 DOI: 10.1212/Wnl.0B013E3182A05Ba5 |
0.354 |
|
| 2013 |
Arnold SE, Toledo JB, Appleby DH, Xie SX, Wang LS, Baek Y, Wolk DA, Lee EB, Miller BL, Lee VM, Trojanowski JQ. Comparative survey of the topographical distribution of signature molecular lesions in major neurodegenerative diseases. The Journal of Comparative Neurology. 521: 4339-55. PMID 23881776 DOI: 10.1002/Cne.23430 |
0.364 |
|
| 2013 |
Toledo JB, Arnold SE, Raible K, Brettschneider J, Xie SX, Grossman M, Monsell SE, Kukull WA, Trojanowski JQ. Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre. Brain : a Journal of Neurology. 136: 2697-706. PMID 23842566 DOI: 10.1093/Brain/Awt188 |
0.407 |
|
| 2013 |
Toledo JB, Xie SX, Trojanowski JQ, Shaw LM. Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI. Acta Neuropathologica. 126: 659-70. PMID 23812320 DOI: 10.1007/S00401-013-1151-4 |
0.377 |
|
| 2013 |
Qiang JK, Wong YC, Siderowf A, Hurtig HI, Xie SX, Lee VM, Trojanowski JQ, Yearout D, B Leverenz J, Montine TJ, Stern M, Mendick S, Jennings D, Zabetian C, Marek K, et al. Plasma apolipoprotein A1 as a biomarker for Parkinson disease. Annals of Neurology. 74: 119-27. PMID 23447138 DOI: 10.1002/Ana.23872 |
0.312 |
|
| 2013 |
Tan KS, Libon DJ, Rascovsky K, Grossman M, Xie SX. Differential longitudinal decline on the Mini-Mental State Examination in frontotemporal lobar degeneration and Alzheimer disease. Alzheimer Disease and Associated Disorders. 27: 310-5. PMID 23314064 DOI: 10.1097/Wad.0B013E31827Bdc6F |
0.374 |
|
| 2013 |
Roalf DR, Moberg PJ, Xie SX, Wolk DA, Moelter ST, Arnold SE. Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 529-37. PMID 23260866 DOI: 10.1016/J.Jalz.2012.10.001 |
0.412 |
|
| 2013 |
Negash S, Xie S, Davatzikos C, Clark CM, Trojanowski JQ, Shaw LM, Wolk DA, Arnold SE. Cognitive and functional resilience despite molecular evidence of Alzheimer's disease pathology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: e89-95. PMID 23127468 DOI: 10.1016/J.Jalz.2012.01.009 |
0.427 |
|
| 2013 |
Arnold SE, Vega IE, Karlawish JH, Wolk DA, Nunez J, Negron M, Xie SX, Wang LS, Dubroff JG, McCarty-Wood E, Trojanowski JQ, Van Deerlin V. Frequency and clinicopathological characteristics of presenilin 1 Gly206Ala mutation in Puerto Rican Hispanics with dementia. Journal of Alzheimer's Disease : Jad. 33: 1089-95. PMID 23114514 DOI: 10.3233/Jad-2012-121570 |
0.374 |
|
| 2013 |
Leung YY, Toledo J, Nefedov A, Polikar R, Raghavan N, Xie S, Farnum M, Schultz T, Baek Y, Lobanov V, DiBernardo A, Deerlin VV, Kling M, Chen-Plotkin A, Mailman M, et al. Identifying multi-analyte CSF biomarkers for Alzheimer’s disease in a multi-cohort study Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.04.059 |
0.313 |
|
| 2012 |
Yarchoan M, Xie SX, Kling MA, Toledo JB, Wolk DA, Lee EB, Van Deerlin V, Lee VM, Trojanowski JQ, Arnold SE. Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias. Brain : a Journal of Neurology. 135: 3749-56. PMID 23204143 DOI: 10.1093/Brain/Aws271 |
0.408 |
|
| 2012 |
Irwin DJ, White MT, Toledo JB, Xie SX, Robinson JL, Van Deerlin V, Lee VM, Leverenz JB, Montine TJ, Duda JE, Hurtig HI, Trojanowski JQ. Neuropathologic substrates of Parkinson disease dementia. Annals of Neurology. 72: 587-98. PMID 23037886 DOI: 10.1002/Ana.23659 |
0.435 |
|
| 2012 |
Toledo JB, Brettschneider J, Grossman M, Arnold SE, Hu WT, Xie SX, Lee VM, Shaw LM, Trojanowski JQ. CSF biomarkers cutoffs: the importance of coincident neuropathological diseases. Acta Neuropathologica. 124: 23-35. PMID 22526019 DOI: 10.1007/S00401-012-0983-7 |
0.404 |
|
| 2012 |
Patel S, Lee EB, Xie SX, Law A, Jackson EM, Arnold SE, Clark CM, Shaw LM, Grady MS, Trojanowski JQ, Hamilton RH. Phosphorylated tau/amyloid beta 1-42 ratio in ventricular cerebrospinal fluid reflects outcome in idiopathic normal pressure hydrocephalus. Fluids and Barriers of the Cns. 9: 7. PMID 22444461 DOI: 10.1186/2045-8118-9-7 |
0.381 |
|
| 2012 |
Zhang B, Carroll J, Trojanowski JQ, Yao Y, Iba M, Potuzak JS, Hogan AM, Xie SX, Ballatore C, Smith AB, Lee VM, Brunden KR. The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 3601-11. PMID 22423084 DOI: 10.1523/Jneurosci.4922-11.2012 |
0.345 |
|
| 2012 |
Irwin DJ, Cohen TJ, Grossman M, Arnold SE, Xie SX, Lee VM, Trojanowski JQ. Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies. Brain : a Journal of Neurology. 135: 807-18. PMID 22366796 DOI: 10.1093/Brain/Aws013 |
0.377 |
|
| 2012 |
Morley JF, Xie SX, Hurtig HI, Stern MB, Colcher A, Horn S, Dahodwala N, Duda JE, Weintraub D, Chen-Plotkin AS, Van Deerlin V, Falcone D, Siderowf A. Genetic influences on cognitive decline in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 512-8. PMID 22344634 DOI: 10.1002/Mds.24946 |
0.408 |
|
| 2012 |
Ash S, Xie SX, Gross RG, Dreyfuss M, Boller A, Camp E, Morgan B, O'Shea J, Grossman M. The organization and anatomy of narrative comprehension and expression in Lewy body spectrum disorders. Neuropsychology. 26: 368-84. PMID 22309984 DOI: 10.1037/A0027115 |
0.349 |
|
| 2012 |
Chin AL, Negash S, Xie S, Arnold SE, Hamilton R. Quality, and not just quantity, of education accounts for differences in psychometric performance between african americans and white non-hispanics with Alzheimer's disease. Journal of the International Neuropsychological Society : Jins. 18: 277-85. PMID 22300593 DOI: 10.1017/S1355617711001688 |
0.355 |
|
| 2012 |
Brettschneider J, Libon DJ, Toledo JB, Xie SX, McCluskey L, Elman L, Geser F, Lee VM, Grossman M, Trojanowski JQ. Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis. Acta Neuropathologica. 123: 395-407. PMID 22210083 DOI: 10.1007/S00401-011-0932-X |
0.376 |
|
| 2012 |
Weintraub D, Dietz N, Duda JE, Wolk DA, Doshi J, Xie SX, Davatzikos C, Clark CM, Siderowf A. Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease. Brain : a Journal of Neurology. 135: 170-80. PMID 22108576 DOI: 10.1093/Brain/Awr277 |
0.431 |
|
| 2012 |
Irwin D, White M, Toledo J, Xie S, Robinson J, Van Deerlin V, Leverenz J, Montine T, Lee V, Duda J, Hurtig H, Trojanowski J. Neuropathologic substrates of Parkinson's disease dementia (S52.002) Neurology. 78: S52.002-S52.002. DOI: 10.1212/Wnl.78.1_Meetingabstracts.S52.002 |
0.364 |
|
| 2012 |
Toledo J, Brettschneider J, Grossman M, Arnold S, Hu W, Xie S, Lee V, Shaw L, Trojanowski J. Improving Diagnostic Accuracy for Dementia: CSF Biomarker Cutoffs Based on Clinical and Neuropathological Criteria (IN3-1.010) Neurology. 78: IN3-1.010-IN3-1.010. DOI: 10.1212/Wnl.78.1_Meetingabstracts.In3-1.010 |
0.328 |
|
| 2012 |
Moelter S, Glenn M, Xie SX, Chittams J, Arnold S, Clark C. P1-074: The Dementia Severity Rating Scale for dementia: Relationships with the CDR sum of boxes, clinical diagnosis and CSF biomarkers Alzheimer's & Dementia. 8: P132-P132. DOI: 10.1016/J.Jalz.2012.05.350 |
0.374 |
|
| 2012 |
Farnum M, Baek Y, Schultz T, Nefedov A, Xie S, Leung YY, Toledo J, Raghavan N, Chen-Plotkin A, Wolk D, Polikar R, DiBernardo A, Siderowf A, Davatzikos C, Van Deerlin V, et al. P1-006: An integrated approach to the development of biomarkers for Alzheimer's disease using hospital population data Alzheimer's & Dementia. 8: P109-P109. DOI: 10.1016/J.Jalz.2012.05.281 |
0.316 |
|
| 2012 |
Yarchoan M, Xie SX, Kling MA, Toledo JB, Wolk DA, Lee EB, Van Deerlin VM, Virginia ML, Trojanowski JQ, Arnold SE. S5-02-04: Relationships of cerebrovascular atherosclerosis with amyloid, tau, α-synuclein and TDP-43 pathologies in neurodegenerative disease dementias Alzheimer's & Dementia. 8: P725-P725. DOI: 10.1016/J.Jalz.2012.05.1951 |
0.376 |
|
| 2012 |
Moelter S, Clark C, Xie SX, Glenn M, Chittams J, Arnold S. O4-10-03: Detecting reliable change in cognitive and functional measures of mild cognitive impairment and Alzheimer's disease Alzheimer's & Dementia. 8: P634-P634. DOI: 10.1016/J.Jalz.2012.05.1691 |
0.363 |
|
| 2012 |
Nefedov A, Toledo J, Leung YY, Raghavan N, Xie S, Polikar R, Farnum M, Schultz T, Baek Y, Lobanov V, DiBernardo A, Narayan V, Lee V, Arnold S, Trojanowski J, et al. P3-101: Neuropathological subtypes among subjects with Alzheimer's disease Alzheimer's & Dementia. 8: P488-P488. DOI: 10.1016/J.Jalz.2012.05.1321 |
0.364 |
|
| 2011 |
Weintraub D, Doshi J, Koka D, Davatzikos C, Siderowf AD, Duda JE, Wolk DA, Moberg PJ, Xie SX, Clark CM. Neurodegeneration across stages of cognitive decline in Parkinson disease. Archives of Neurology. 68: 1562-8. PMID 22159053 DOI: 10.1001/Archneurol.2011.725 |
0.361 |
|
| 2011 |
Libon DJ, Rascovsky K, Gross RG, White MT, Xie SX, Dreyfuss M, Boller A, Massimo L, Moore P, Kitain J, Coslett HB, Chatterjee A, Grossman M. The Philadelphia Brief Assessment of Cognition (PBAC): a validated screening measure for dementia. The Clinical Neuropsychologist. 25: 1314-30. PMID 22084867 DOI: 10.1080/13854046.2011.631585 |
0.385 |
|
| 2011 |
Venneti S, Robinson JL, Roy S, White MT, Baccon J, Xie SX, Trojanowski JQ. Simulated brain biopsy for diagnosing neurodegeneration using autopsy-confirmed cases. Acta Neuropathologica. 122: 737-45. PMID 21959586 DOI: 10.1007/S00401-011-0880-5 |
0.341 |
|
| 2011 |
Toledo JB, Vanderstichele H, Figurski M, Aisen PS, Petersen RC, Weiner MW, Jack CR, Jagust W, Decarli C, Toga AW, Toledo E, Xie SX, Lee VM, Trojanowski JQ, Shaw LM, et al. Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI. Acta Neuropathologica. 122: 401-13. PMID 21805181 DOI: 10.1007/S00401-011-0861-8 |
0.343 |
|
| 2011 |
Xie SX, Baek Y, Grossman M, Arnold SE, Karlawish J, Siderowf A, Hurtig H, Elman L, McCluskey L, Van Deerlin V, Lee VM, Trojanowski JQ. Building an integrated neurodegenerative disease database at an academic health center. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: e84-93. PMID 21784346 DOI: 10.1016/J.Jalz.2010.08.233 |
0.367 |
|
| 2011 |
Livney MG, Clark CM, Karlawish JH, Cartmell S, Negrón M, Nuñez J, Xie SX, Entenza-Cabrera F, Vega IE, Arnold SE. Ethnoracial differences in the clinical characteristics of Alzheimer's disease at initial presentation at an urban Alzheimer's disease center. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 19: 430-9. PMID 21522051 DOI: 10.1097/Jgp.0B013E3181F7D881 |
0.409 |
|
| 2011 |
Chen-Plotkin AS, Hu WT, Siderowf A, Weintraub D, Goldmann Gross R, Hurtig HI, Xie SX, Arnold SE, Grossman M, Clark CM, Shaw LM, McCluskey L, Elman L, Van Deerlin VM, Lee VM, et al. Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease. Annals of Neurology. 69: 655-63. PMID 21520231 DOI: 10.1002/Ana.22271 |
0.367 |
|
| 2011 |
Geser F, Stein B, Partain M, Elman LB, McCluskey LF, Xie SX, Van Deerlin VM, Kwong LK, Lee VM, Trojanowski JQ. Motor neuron disease clinically limited to the lower motor neuron is a diffuse TDP-43 proteinopathy. Acta Neuropathologica. 121: 509-17. PMID 21225272 DOI: 10.1007/S00401-011-0797-Z |
0.32 |
|
| 2011 |
Negash S, Xie SX, Davatzikos C, Wolk D, Arnold S. P2-053: Factors associated with cognitive and functional resilience despite molecular evidence of Alzheimer's disease pathology Alzheimer's & Dementia. 7: S324-S324. DOI: 10.1016/J.Jalz.2011.05.942 |
0.395 |
|
| 2011 |
Negash S, Chin A, Xie S, Arnold S, Hamilton R. P1-450: Quality, and not just quantity, of education accounts for ethnoracial differences in neuropsychological performance in Alzheimer's disease Alzheimer's & Dementia. 7: S257-S258. DOI: 10.1016/J.Jalz.2011.05.732 |
0.329 |
|
| 2011 |
Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Xie S, van Swieten JC, Seelaar H, Dopper EG, Onyike CU, Hillis A, Josephs KA, Boeve BF, Kertesz A, Seeley WW, et al. P4-166: Determinants of survival in autopsy-confirmed patients with behavioral variant frontotemporal dementia (bvFTD): Second Report of the international bvFTD criteria consortium (FTDC) Alzheimer's & Dementia. 7: S761-S762. DOI: 10.1016/J.Jalz.2011.05.2188 |
0.315 |
|
| 2011 |
Steinberg S, Livney M, Kling M, McCoubrey H, Yuen S, Edwards C, Xie SX, Arnold S. P3-279: Predictors of resilient cognitive aging: Baseline characteristics Alzheimer's & Dementia. 7: S605-S606. DOI: 10.1016/J.Jalz.2011.05.1721 |
0.308 |
|
| 2011 |
Bilello M, Doshi J, Xie S, Arnold S, Davatzikos C. IC-P-032: Association of brain atrophy and vascular white matter lesions with CERAD score in Alzheimer's disease Alzheimer's & Dementia. 7: S21-S21. DOI: 10.1016/J.Jalz.2011.05.048 |
0.343 |
|
| 2010 |
Brunden KR, Zhang B, Carroll J, Yao Y, Potuzak JS, Hogan AM, Iba M, James MJ, Xie SX, Ballatore C, Smith AB, Lee VM, Trojanowski JQ. Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 13861-6. PMID 20943926 DOI: 10.1523/Jneurosci.3059-10.2010 |
0.346 |
|
| 2010 |
Geser F, Robinson JL, Malunda JA, Xie SX, Clark CM, Kwong LK, Moberg PJ, Moore EM, Van Deerlin VM, Lee VM, Arnold SE, Trojanowski JQ. Pathological 43-kDa transactivation response DNA-binding protein in older adults with and without severe mental illness. Archives of Neurology. 67: 1238-50. PMID 20937952 DOI: 10.1001/Archneurol.2010.254 |
0.333 |
|
| 2010 |
Rubright J, Sankar P, Casarett DJ, Gur R, Xie SX, Karlawish J. A memory and organizational aid improves Alzheimer disease research consent capacity: results of a randomized, controlled trial. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 18: 1124-32. PMID 20808101 DOI: 10.1097/Jgp.0B013E3181Dd1C3B |
0.353 |
|
| 2010 |
Siderowf A, Xie SX, Hurtig H, Weintraub D, Duda J, Chen-Plotkin A, Shaw LM, Van Deerlin V, Trojanowski JQ, Clark C. CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease. Neurology. 75: 1055-61. PMID 20720189 DOI: 10.1212/Wnl.0B013E3181F39A78 |
0.427 |
|
| 2010 |
Hamilton R, Patel S, Lee EB, Jackson EM, Lopinto J, Arnold SE, Clark CM, Basil A, Shaw LM, Xie SX, Grady MS, Trojanowski JQ. Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology. Annals of Neurology. 68: 535-40. PMID 20687117 DOI: 10.1002/Ana.22015 |
0.418 |
|
| 2010 |
Stephenson R, Houghton D, Sundarararjan S, Doty RL, Stern M, Xie SX, Siderowf A. Odor identification deficits are associated with increased risk of neuropsychiatric complications in patients with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 2099-104. PMID 20669288 DOI: 10.1002/Mds.23234 |
0.344 |
|
| 2010 |
Rosenthal E, Brennan L, Xie S, Hurtig H, Milber J, Weintraub D, Karlawish J, Siderowf A. Association between cognition and function in patients with Parkinson disease with and without dementia. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 1170-6. PMID 20310053 DOI: 10.1002/Mds.23073 |
0.406 |
|
| 2010 |
Trojanowski JQ, Arnold SE, Karlawish JH, Brunden K, Cary M, Davatzikos C, Detre J, Gaulton G, Grossman M, Hurtig H, Jedrziewski K, McCluskey L, Naylor M, Polsky D, Schellenberg GD, ... ... Xie SX, et al. Design of comprehensive Alzheimer's disease centers to address unmet national needs. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 150-5. PMID 20298979 DOI: 10.1016/J.Jalz.2009.11.004 |
0.37 |
|
| 2010 |
Xie SX, Libon DJ, Wang X, Massimo L, Moore P, Vesely L, Khan A, Chatterjee A, Coslett HB, Hurtig HI, Liang TW, Grossman M. Longitudinal patterns of semantic and episodic memory in frontotemporal lobar degeneration and Alzheimer's disease. Journal of the International Neuropsychological Society : Jins. 16: 278-86. PMID 20003584 DOI: 10.1017/S1355617709991317 |
0.368 |
|
| 2010 |
Libon DJ, Xie SX, Eppig J, Wicas G, Lamar M, Lippa C, Bettcher BM, Price CC, Giovannetti T, Swenson R, Wambach DM. The heterogeneity of mild cognitive impairment: a neuropsychological analysis. Journal of the International Neuropsychological Society : Jins. 16: 84-93. PMID 19887015 DOI: 10.1017/S1355617709990993 |
0.315 |
|
| 2009 |
Hoops S, Nazem S, Siderowf AD, Duda JE, Xie SX, Stern MB, Weintraub D. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology. 73: 1738-45. PMID 19933974 DOI: 10.1212/Wnl.0B013E3181C34B47 |
0.386 |
|
| 2009 |
Lukens JN, Van Deerlin V, Clark CM, Xie SX, Johnson FB. Comparisons of telomere lengths in peripheral blood and cerebellum in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 5: 463-9. PMID 19896585 DOI: 10.1016/J.Jalz.2009.05.666 |
0.356 |
|
| 2009 |
Xie SX, Ewbank DC, Chittams J, Karlawish JH, Arnold SE, Clark CM. Rate of decline in Alzheimer disease measured by a Dementia Severity Rating Scale. Alzheimer Disease and Associated Disorders. 23: 268-74. PMID 19812470 DOI: 10.1097/Wad.0B013E318194A324 |
0.376 |
|
| 2009 |
Libon DJ, Xie SX, Wang X, Massimo L, Moore P, Vesely L, Khan A, Chatterjee A, Coslett HB, Hurtig HI, Liang TW, Grossman M. Neuropsychological decline in frontotemporal lobar degeneration: a longitudinal analysis. Neuropsychology. 23: 337-46. PMID 19413447 DOI: 10.1037/A0014995 |
0.407 |
|
| 2009 |
Geser F, Martinez-Lage M, Robinson J, Uryu K, Neumann M, Brandmeir NJ, Xie SX, Kwong LK, Elman L, McCluskey L, Clark CM, Malunda J, Miller BL, Zimmerman EA, Qian J, et al. Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Archives of Neurology. 66: 180-9. PMID 19204154 DOI: 10.1001/Archneurol.2008.558 |
0.348 |
|
| 2009 |
Mao J, Stricker C, Bruner D, Farrar J, Bowman M, Xie S, Wolf J, DeMichele A. Onset and risk factors for aromatase inhibitor-related arthralgia in breast cancer survivors. Cancer Research. 69: 1120. DOI: 10.1158/0008-5472.Sabcs-1120 |
0.309 |
|
| 2009 |
Mao J, Gehrman P, Su I, Bruner D, Xie S, Sehamy AE, DeMichele A. Prevalence and Risk Factors for Insomnia in Breast Cancer Survivors Receiving Aromatase Inhibitors. Cancer Research. 69: 1062-1062. DOI: 10.1158/0008-5472.Sabcs-09-1062 |
0.306 |
|
| 2008 |
Geser F, Brandmeir NJ, Kwong LK, Martinez-Lage M, Elman L, McCluskey L, Xie SX, Lee VM, Trojanowski JQ. Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Archives of Neurology. 65: 636-41. PMID 18474740 DOI: 10.1001/Archneur.65.5.636 |
0.301 |
|
| 2008 |
Grossman M, Xie SX, Libon DJ, Wang X, Massimo L, Moore P, Vesely L, Berkowitz R, Chatterjee A, Coslett HB, Hurtig HI, Forman MS, Lee VM, Trojanowski JQ. Longitudinal decline in autopsy-defined frontotemporal lobar degeneration. Neurology. 70: 2036-45. PMID 18420483 DOI: 10.1212/01.Wnl.0000303816.25065.Bc |
0.339 |
|
| 2008 |
Geser F, Winton MJ, Kwong LK, Xu Y, Xie SX, Igaz LM, Garruto RM, Perl DP, Galasko D, Lee VM, Trojanowski JQ. Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. Acta Neuropathologica. 115: 133-45. PMID 17713769 DOI: 10.1007/S00401-007-0257-Y |
0.308 |
|
| 2008 |
Xie SX, Forman MS, Farmer J, Moore P, Wang Y, Wang X, Clark CM, Coslett HB, Chatterjee A, Arnold SE, Rosen H, Karlawish JH, Van Deerlin VM, Lee VM, Trojanowski JQ, et al. Factors associated with survival probability in autopsy-proven frontotemporal lobar degeneration. Journal of Neurology, Neurosurgery, and Psychiatry. 79: 126-9. PMID 17615171 DOI: 10.1136/Jnnp.2006.110288 |
0.359 |
|
| 2008 |
Cartmell SP, Xie SX, Martinez P, Nunez J, Janis P, Baek Y, Karlawish JHT, Arnold SE, Clark CM. P3-007: Instability of a diagnosis of mild cognitive impairment based on a brief screening assessment of English- and Spanish-speaking individuals in a general care clinic Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1570 |
0.324 |
|
| 2008 |
Xie SX, Davatzikos C, Chittams J, Wu X, Leight S, Lee VM, Trojanowski JQ, Clark CM. P2-098: Comparison of diagnostics values of cerebrospinal fluid tau and structural magnetic resonance imaging in classifying patients with Alzheimer's disease versus normal subjects Alzheimer's & Dementia. 4: T399-T399. DOI: 10.1016/J.Jalz.2008.05.1171 |
0.333 |
|
| 2007 |
Nakashima-Yasuda H, Uryu K, Robinson J, Xie SX, Hurtig H, Duda JE, Arnold SE, Siderowf A, Grossman M, Leverenz JB, Woltjer R, Lopez OL, Hamilton R, Tsuang DW, Galasko D, et al. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathologica. 114: 221-9. PMID 17653732 DOI: 10.1007/S00401-007-0261-2 |
0.421 |
|
| 2007 |
Weintraub D, Xie S, Karlawish J, Siderowf A. Differences in depression symptoms in patients with Alzheimer's and Parkinson's diseases: Evidence from the 15-item Geriatric Depression Scale (GDS-15) International Journal of Geriatric Psychiatry. 22: 1025-1030. PMID 17562521 DOI: 10.1002/Gps.1785 |
0.378 |
|
| 2007 |
Libon DJ, Xie SX, Moore P, Farmer J, Antani S, McCawley G, Cross K, Grossman M. Patterns of neuropsychological impairment in frontotemporal dementia. Neurology. 68: 369-75. PMID 17261685 DOI: 10.1212/01.Wnl.0000252820.81313.9B |
0.351 |
|
| 2006 |
Clark CM, Pratico D, Shaw LM, Leight S, Xie SX, Gu A, Lee VM, Trojanowski JQ. Commentary on "Optimal design of clinical trials for drugs designed to slow the course of Alzheimer's disease." Biochemical biomarkers of late-life dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 2: 287-93. PMID 19595902 DOI: 10.1016/J.Jalz.2006.05.2347 |
0.433 |
|
| 2006 |
Siderowf A, Jaggi JL, Xie SX, Loveland-Jones C, Leng L, Hurtig H, Colcher A, Stern M, Chou KL, Liang G, Maccarone H, Simuni T, Baltuch G. Long-term effects of bilateral subthalamic nucleus stimulation on health-related quality of life in advanced Parkinson's disease. Movement Disorders. 21: 746-753. PMID 16463342 DOI: 10.1002/Mds.20786 |
0.308 |
|
| 2006 |
Da Re F, Phillips JS, Xie SX, Ferrarese C, McMillan CT, Irwin DJ, Grossman M. IC-06-03: DISTINCT LONGITUDINAL CORTICAL ATROPHY IN NON-AMNESTIC COMPARED TO AMNESTIC ALZHEIMER'S DISEASE SUGGESTS DIFFERENT PATTERNS OF SPREADING PATHOLOGY Alzheimer's & Dementia. 14: P12-P12. DOI: 10.1016/J.Jalz.2018.06.2056 |
0.347 |
|
| 2006 |
Clark CM, Topalis A, Green DL, Stepenosky N, Gandhi H, McCoubrey H, Kounios J, Xie S, Polikar R. P1-154: Auditory event related potentials: A candidate physiologic biomarker for early detection of neurodegeneration associated with Alzheimer disease Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.530 |
0.326 |
|
| 2005 |
Hirschman KB, Joyce CM, James BD, Xie SX, Casarett DJ, Karlawish JHT. Would caregivers of Alzheimer disease patients involve their relative in a decision to use an AD-slowing medication? American Journal of Geriatric Psychiatry. 13: 1014-1021. PMID 16286446 DOI: 10.1097/00019442-200511000-00013 |
0.341 |
|
| 2005 |
James BD, Xie SX, Karlawish JHT. How do patients with Alzheimer disease rate their overall quality of life? The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry.. 13: 484-490. PMID 15956268 DOI: 10.1097/00019442-200506000-00007 |
0.348 |
|
| 2005 |
Karlawish JHT, Casarett DJ, James BD, Xie SX, Kim SYH. The ability of persons with Alzheimer disease (AD) to make a decision about taking an AD treatment Neurology. 64: 1514-1519. PMID 15883310 DOI: 10.1212/01.Wnl.0000160000.01742.9D |
0.377 |
|
| 2004 |
Hirschman KB, Shea JA, Xie SX, Karlawish JHT. The development of a rapid screen for caregiver burden Journal of the American Geriatrics Society. 52: 1724-1729. PMID 15450052 DOI: 10.1111/J.1532-5415.2004.52468.X |
0.34 |
|
| 2004 |
Hirschman KB, Xie SX, Feudtner C, Karlawish JHT. How does an Alzheimer's disease patient's role in medical decision making change over time? Journal of Geriatric Psychiatry and Neurology. 17: 55-60. PMID 15157344 DOI: 10.1177/0891988704264540 |
0.331 |
|
| 2004 |
Clark CM, Pratico D, Xie S, Trojanowski JQ. P3-052 Elevated CSF 8,12 isoprostane F2α-VL levels predict the presence of Alzheimer pathology Neurobiology of Aging. 25: S366. DOI: 10.1016/S0197-4580(04)81205-3 |
0.31 |
|
| 2004 |
Clark CM, Xie S, Chittams J, Karlawish J, Arnold SE, Ewbank DC. P1-015 The dementia severity rating scale, a knowledgeable informant measure of dementia symptom severity, provides a reliable and clinically efficient measure of Alzheimer's disease progression from the time of initial evaluation to the severe impairment stage Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80329-4 |
0.38 |
|
| 2003 |
Clark CM, Xie S, Chittams J, Ewbank D, Peskind E, Galasko D, Morris JC, McKeel DW, Farlow M, Weitlauf SL, Quinn J, Kaye J, Knopman D, Arai H, Doody RS, et al. Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Archives of Neurology. 60: 1696-702. PMID 14676043 DOI: 10.1001/Archneur.60.12.1696 |
0.401 |
|
| Show low-probability matches. |